A novel alkylating agent Melflufen induces irreversible DNA damage and cytotoxicity in multiple myeloma cells-Reference-Cited by-同舟云学术

A novel alkylating agent Melflufen induces irreversible DNA damage and cytotoxicity in multiple myeloma cells

Published:2016-04-20 Issue:3 Volume:174 Page:397-409
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Ray Arghya¹,Ravillah Durgadevi¹,Das Deepika S.¹,Song Yan¹,Nordström Eva²,Gullbo Joachim³,Richardson Paul G.¹,Chauhan Dharminder¹,Anderson Kenneth C.¹

Affiliation:

1. Department of Medical Oncology; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center; Dana-Farber Cancer Institute; Harvard Medical School; Boston MA USA

2. Oncopeptides AB; Karolinska Institutet Science Park; Solna Sweden

3. Department of Immunology, Genetics and Pathology; Section of Oncology; Uppsala University; Uppsala Sweden

Funder

National Institutes of Health Specialized Programs of Research Excellence SPORE

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14065/fullpdf

Reference40 articles.

1. Oncogenomics to target myeloma in the bone marrow microenvironment;Anderson;Clinical Cancer Research,2011

2. The 39th David A. Karnofsky Lecture: bench-to-bedside translation of targeted therapies in multiple myeloma;Anderson;Journal of Clinical Oncology,2012

3. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome;Attal;New England Journal of Medicine,1996

4. Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III USIntergroup Trial S9321;Barlogie;Journal of Clinical Oncology,2006

5. Phase I/II trial assessing bortezomib and melphalan combination therapy for the treatment of patients with relapsed or refractory multiple myeloma;Berenson;Journal of Clinical Oncology,2006

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The emerging role of melflufen and peptide-conjugates in multiple myeloma;Current Opinion in Oncology;2024-08-22

2. Targeted Drug Conjugates in Cancer Therapy: Challenges and Opportunities;Pharmaceutical Science Advances;2024-08

3. Small Molecule–Drug Conjugates Emerge as a New Promising Approach for Cancer Treatment;Molecular Pharmaceutics;2024-02-12

4. Design and synthesis of fluorine aromatic scaffolds containing drugs approved by the US FDA from 2002 to 2022;Results in Chemistry;2024-01

5. Melflufen in relapsed/refractory multiple myeloma refractory to prior alkylators: A subgroup analysis from the OCEAN study;European Journal of Haematology;2023-11-15